შპს ირისე

Medical DevicesDistribution

ID 204955628 · FY 2018–2024 · 7 years

კომპანიის ძირითად საქმიანობას წარმოადგენს სადიაგნოსტიკო ტესტ-სისტემებს და სამედიცინო მოწყობილობების საბითუმო და საცალო რეალიზაცია კომპანიის იურიდიული და ფაქტიური მისამართია საქართველო, 0186, თბილისი, ვაკე-საბურთალოს რაიონი, თამარაშვილის ქ.

curated 2026-07-27

Compare with peers Screen Medical Devices Annual report FY2024

Key metrics

FY2024

Revenue & margins

Bars are revenue on the left axis; lines are EBITDA and net margin on the right.

latest FY 2024: ₾3.7m

Financial statements

consolidated · GEL

FY–financial ratiosXLSX

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	30.8%	28.3%	20.4%	24.1%	34.4%	30.4%	29.1%
EBITDA Margin	16.4%	18.4%	15.6%	14.4%	22.0%	15.3%	12.9%
EBITDAR	594	658	1,563	778	934	545	481
EBITDAR Margin	16.4%	18.4%	15.6%	14.4%	22.0%	15.3%	12.9%
EBIT Margin	16.1%	18.0%	15.5%	14.2%	21.5%	12.8%	10.5%
Net Profit Margin	16.7%	15.4%	15.0%	12.4%	17.6%	10.6%	8.3%
Operating Expense % of Sales	14.4%	9.9%	4.8%	9.7%	12.4%	15.1%	16.2%
Returns
Return on Assets (ROA)	51.4%	45.3%	49.2%	24.7%	29.3%	15.3%	14.4%
Return on Equity (ROE)	66.9%	55.7%	67.9%	29.5%	32.9%	18.2%	16.6%
ROIC [EBIT / Invested Capital]	174.5%	212.5%	113.6%	94.6%	59.1%	33.7%	30.3%
Leverage & liquidity
Debt-to-Assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Debt-to-Equity	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt-to-EBITDA	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Equity-to-Assets	76.8%	81.3%	72.5%	83.8%	89.0%	84.3%	86.8%
Net Debt	-568	-685	-854	-1,460	-727	-722	-573
Cash & Equivalents	568	685	854	1,460	727	722	573
Total Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Efficiency & working capital
Inventory Turnover	N/A	27.75x	41.44x	N/A	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	13.2	8.8	N/A	N/A	N/A	N/A
Receivables Turnover	8.81x	17.80x	5.62x	12.65x	9.45x	7.52x	10.00x
Days Sales Outstanding (DSO)	41.4	20.5	64.9	28.9	38.6	48.6	36.5
Payables Turnover	9.59x	11.93x	9.55x	9.52x	10.67x	6.88x	9.89x
Days Payable Outstanding (DPO)	38.1	30.6	38.2	38.3	34.2	53.0	36.9
Cash Conversion Cycle	3.4 days	3.1 days	35.5 days	-9.5 days	4.4 days	-4.5 days	-0.4 days
Asset Turnover	3.08x	2.95x	3.28x	1.99x	1.66x	1.44x	1.74x
Cash flow & dividends
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow (OCF − Capex proxy)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Conversion (OCF / EBITDA)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Ownership & group structure

Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.

companyinfo.ge · fetched 2026-07-15